SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-03-000232
Filing Date
2003-04-02
Accepted
2003-04-02 09:22:34
Documents
5
Period of Report
2003-05-15
Effectiveness Date
2003-04-02

Document Format Files

Seq Description Document Type Size
1 d12207.htm DEF 14A 149971
3 GRAPHIC avantlogo.jpg GRAPHIC 69667
4 GRAPHIC averywsig.jpg GRAPHIC 6130
5 GRAPHIC jbarriewig.jpg GRAPHIC 7310
6 GRAPHIC performancechart.jpg GRAPHIC 205994
  Complete submission text file 0001206774-03-000232.txt   441096
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 03635439
SIC: 2835 In Vitro & In Vivo Diagnostic Substances